-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on ALX Oncology Holdings, Lowers Price Target to $1

Benzinga·05/21/2025 14:39:47
Listen to the news
UBS analyst Colin Bristow maintains ALX Oncology Holdings (NASDAQ:ALXO) with a Buy and lowers the price target from $1.2 to $1.